Get notified when PIII files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- SEC Investigation (unchanged) — DOJ investigation into broker arrangements remains ongoing with no status change disclosed.
- Delisting (removed) — Detailed delisting risk disclosure removed after company regained compliance through reverse stock split in April 2025.
revenue $386.4M, net income $1.2M. P3 Health swings to profit despite 3.5% membership drop; going concern persists
Filed May 14, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~1 min read
Key Changes
-
high
Q1 2026 net income of loss in Q1 2025, driven by medical margin improvement from favorable reserve development and claims true-up, plus tax benefit from state position releases.
MD&A: Financial Results verify on EDGAR → -
high
Going concern warning unchanged despite profitability; unrestricted cash fell while interest expense doubled from high-cost debt (19.5% notes). Company raised in April 2026 via Series D preferred with 19.5% dividend.
MD&A: Liquidity verify on EDGAR → -
high
At-risk membership declined and affiliate physician network contracted PCPs as company exited underperforming contracts, trading volume for margin in strategic rationalization.
MD&A: Membership verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (EPM 10-K) is open in full — no account needed.
Partner
Trade PIII commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify